/

Società

Au

Non verificato

Aurion Biotech

Di cosa scriviamo

EventiFarmaceuticaMedicina - VarieOtticaSalute

5 comunicati stampa

Guarda tutti i comunicati

18/10/2025

Eventi

Salute

Medicina - Varie

Scienza

Farmaceutica

Ottica

Biotecnologia

Aurion Biotech Achieves All Primary, Secondary, and Exploratory Endpoints in AURN001 Phase 1/2 CLARA Trial at 12 Months

Fonte

Emittente

1.00

0

30/09/2025

Aurion Biotech Expands Leadership Team, Promoting Andrew Torres, Ph.D., to Chief Manufacturing Officer and Sterling Chung to Chief Regulatory & Quality Officer

Fonte

Emittente

1.00

0

23/04/2025

Aurion Biotech Appoints Edward J. Holland, M.D., as Chief Medical Officer and Eris P. Jordan, O.D., as Chief Development Officer

Fonte

Emittente

1.00

0

24/09/2024

Aurion Biotech Launches Vyznova® (neltependocel) in Japan for the Treatment of Bullous Keratopathy of the Cornea

Fonte

Emittente

1.00

0

03/09/2024

Eventi

Fiere

Industria

Farmaceutica

Ottica

Salute

Medicina - Varie

Aurion Biotech to Present at the 42nd Congress of the European Society of Cataract and Refractive Surgeons (ESCRS) and Ophthalmology European Futures Forum

Fonte

Emittente

1.00

0

Seguaci

0

Compatibilità

0